UVA Health

Tweets from UVA Health

Latest from UVA Health

Insights on Vortioxetine for Treatment-Emergent Sexual Dysfunction

December 08, 2018


Investigator Anita Clayton, MD, shares insights into the new vortioxetine data and its implications for patients with depression and treatment-emergent sexual dysfunction.

Robert Battle, MD: Treating Hypertrophic Cardiomyopathy as a Sports Cardiologist

October 25, 2018


Along with sports cardiology and pediatric cardiology, Robert Battle specializes in treating patients with hypertrophic cardiomyopathy, the most common genetic cardiovascular disorder.

Label Update Shows Vortioxetine as Effective for Treatment-Emergent Sexual Dysfunction

October 22, 2018


A supplemental new drug application (sNDA) for vortioxetine (TRINTELLIX), a prescription medication for the treatment of adults with major depressive disorder (MDD), has been accepted by the FDA.

Q&A: J. Michael Mangrum, MD, on UVA's Work with CardioInsight

September 01, 2018


The heart rhythm specialist with the UVA Advanced Imaging group discussed his team's early successes with Medtronic's heart ablation vest.